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were obtained when each zone of AC was analysed separately
and also when data for MCP and MTP joints was analysed
individually.
Conclusions: The apparent linear increase in chondrocyte apop-
tosis at early stages of AC degradation (‘modified’ Mankin grades
0-3) suggests that this process may play a significant role in the
initiation of cartilage damage. This data therefore supports the
notion that cell death by apoptosis may be an important ae-
tiopathogenic mechanism in OA.
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DYNAMIC COMPRESSION COUNTERACTS
FIBRONECTIN FRAGMENT INDUCED UPREGULATION
OF NITRIC OXIDE
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Purpose: The importance of nitric oxide (•NO) as a key mediator
in the pathophysiology of osteoarthritis (OA) has been well docu-
mented. The underlying mechanism involves the induction of •NO
and prostaglandin E2 (PGE2) by pro-inflammatory cytokines, that
lead to the degradation of the extracellular matrix constituents.
Fibronectin is a component of the extracellular matrix. In OA,
fibronectin is degraded into small fragments and these degra-
dation products could play a major role in cartilage breakdown.
Recent studies have shown that fibronectin fragments (Fn-F)
enhance the release of •NO and/or matrix metalloproteinase
(MMP) enzymes. However, these studies focused primarily on
the pathways in the absence of mechanical stimuli. We have pre-
viously shown that dynamic compression counteracts •NO and
PGE2 release in the presence of IL-1β. The current study exam-
ines the biochemical changes observed by chondrocyte/agarose
constructs subjected to dynamic compression in the presence of
Fn-F.
Methods: Initial dose response studies were conducted under
free-swelling conditions in order to determine the appropriate
concentration of Fn-F for the mechanical loading studies. Chon-
drocyte/agarose constructs were cultured for 48 hours in radio-
labelled media containing 0, 0.01, 0.1, 1 or 10 μg ml-1 of the
heparin binding 40 kDa Fn-F, +/- 1 mM L-NIO (NOS inhibitor).
For the mechanical loading studies, constructs were subjected
to 15% dynamic compressive strain at 1 Hz frequency for 48
hours in media supplemented with 0 or 10 μg ml-1 Fn-F, +/- 1
mM 1400 W (iNOS inhibitor). Nitrite and PGE2 release, [3H]-
thymidine and 35SO4 incorporation were measured using well
established biochemical assays.
Results: Fn-F at concentrations of 0.1, 1 and 10 μg ml-1 in-
creased nitrite release when compared to control constructs (all
p<0.001). L-NIO downregulated nitrite release when constructs
were cultured with 10 μg.ml-1Fn-F (p<0.05). By contrast, Fn-F
did not significantly influence PGE2 release in the presence and
absence of L-NIO. [3H]-thymidine incorporation was downregu-
lated with 1 and 10 μg.ml-1 Fn-F when compared to control con-
structs (p<0.05 and p<0.001). 10 μg.ml-1 Fn-F inhibited 35SO4
incorporation when compared to control construct (p.0.001) and
this response was reversed by L-NIO (p<0.01).
In unstrained constructs, 10 μg.ml-1 Fn-F upregulated nitrite re-
lease when compared to control constructs (p<0.001). Dynamic
compression inhibited nitrite release in the absence and pres-
ence of Fn-F (both p<0.001) and this effect was abolished with
1400 W. Dynamic compression in the presence and absence of
Fn-F did not significantly influence PGE2 release (Fig. 2B). In
unstrained constructs, Fn-F and 1400 W increased PGE2 release
when compared to control constructs (p<0.01). This effect was
not influenced by dynamic compression. In the absence of Fn-F,
dynamic compression upregulated [3H]-thymidine (p<0.001) and
35SO4 incorporation (p<0.01). The upregulation of [3H]-thymidine
and 35SO4 incorporation by dynamic compression was abolished
with Fn-F and enhanced with 1400 W (p<0.001 and p<0.01,
respectively).
Conclusions: The current study demonstrates that Fn-F stim-
ulates •NO release and this effect could be abolished by me-
chanical load. PGE2 levels were not influenced by the presence
of Fn-F, suggesting alternative pathways which could activate
IL-1β and/or MMP expression. Thus, a suppression of •NO is
important in mediating the upregulation of cell proliferation and
proteoglycan synthesis in response to dynamic compression.
Further characterization of the mechanotransduction pathway in
the presence of inflammatory mediators may identify pharmaco-
logical targets for the treatment of OA.
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Purpose: Interleukin-1β (IL-1β) stimulated chondrocytes produce
a variety of mediators of cartilage degradation including matrix
metalloproteinases (MMPs) that play a pivotal role in joint de-
struction in osteoarthritis (OA). The objective of this study was to
characterize the high molecular weight (HMW) MMPs produced
by IL-1β-stimulated OA chondrocytes that are also found in the
synovial fluid of OA joints.
Methods: Chondrocytes were prepared by enzymatic digestion
of OA cartilage. Nearly confluent chondrocyte cultures were
serum-starved overnight and stimulated with IL-1β for different
time periods. Substrate-embedded enzymography and collagen
degradation assays were used to characterize the MMP activity
in chondrocyte conditioned media and also in OA synovial fluid.
Western immunoblotting and immunoprecipitation was used to
confirm the presence of specific MMP proteins. Chondrocyte
nucleofection with small interfering RNAs (siRNAs) was used
to knockdown MMP-9, MMP-13 and NGAL gene expression.
Quantitative RT-PCR was employed to quantify MMP and NGAL
mRNA expression. Cartilage explants were stained with Safranin-
O/Fast Green and proteoglycan and collagen degradation was
determined in the cell culture supernatant with metachromatic
dye assays.
Results: One of the HMW MMPs of ∼130-kDa found in OA
synovial fluid was a complex of MMP-9 and NGAL. Immunologi-
cal, biochemical and molecular biology approaches were used to
confirm this result. Western immunoblotting showed that OA syn-
ovial fluid contained high levels of NGAL, MMP-9, and MMP-13
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as well as HMW proteins that cross-reacted with anti-NGAL and
anti-MMP-9 antibodies but not with the anti-MMP-13 antibody.
In addition, anti-NGAL antibody or anti-MMP-9 antibody, but not
anti-MMP-13 antibody, was able to specifically immunoprecipi-
tate the ∼130-kDa HMW synovial fluid MMP activity. Conditioned
media from chondrocytes stimulated with IL-1β also showed el-
evated levels of the MMP-9/NGAL complex and MMP-9 activity,
detected by Western immunoblotting and enzymography, re-
spectively. Additional studies showed that the HMW synovial
fluid MMP-9 activity co-migrated with a purified MMP-9/NGAL
complex on a gelatin zymogram. Furthermore, the MMP-9/NGAL
complex could be reconstituted in vitro by mixing recombinant
human MMP-9 and NGAL in gelatinase assay buffer. The ex-
pression of MMP-9 and NGAL mRNA was enhanced several fold
in IL-1β-treated human OA chondrocytes. Conditioned medium
of human chondrocytes transfected with either NGAL or MMP-9
siRNA showed significantly lower MMP-9/NGAL complex levels
when compared to chondrocytes cultures transfected with MMP-
13 siRNA (P<0.05). Recombinant human MMP-9 incubated in
gelatinase assay buffer in the absence of NGAL showed rapid
MMP-9 degradation with loss of MMP-9 activity. Histochemical
and biochemical analysis of human cartilage explants showed
that proteoglycan and Type II collagen content loss was signifi-
cantly elevated when NGAL was added exogenously to human
cartilage explant cultures stimulated with IL-1β (p <0.05).
Conclusions: IL-1β-stimulated human chondrocytes expressed
NGAL and MMP-9 which combined to form a HMW active MMP-
9/NGAL complex. These results showed that the MMP-9/NGAL
complex protected MMP-9 from auto-degradation since a rapid
loss of MMP-9 activity was detected in the absence of NGAL.
These results suggested that NGAL inhibition may be a useful
therapeutic approach for suppressing cartilage degradation in
OA.
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Purpose: Activation of toll-like receptors (TLR) by endogenous
ligands has been suggested as a mechanism for response to
tissue damage. Both TLR-2 and TLR-4 have been implicated
in this process. Our recent work has suggested that expression
of the chitinase 3-like protein (Chi3L) 1 in rat chondrocytes
is controlled mainly by the NF-kappa B signalling pathway, a
major component of the toll-like receptor (TLR) signalling system,
suggesting that its production could be part of the cells’ response
to activation of TLRs. In contrast to rodent chondrocytes, human
cells express two forms of Chi3L proteins, designated 1 and 2.
The aim of the work reported below was to investigate whether
expression of both Chi3L proteins in articular chondrocytes was
part of the TLR-response in these cells and whether or not their
expression was co-ordinated in human cartilage.
Methods: Articular chondrocytes were isolated from femoral
heads of neonatal rats and used in primary cultures. Human
articular chondrocytes were isolated from cartilage harvested
from the femoral condyles and tibial plateaus of a juvenile donor.
Frozen stocks at passage levels 3 to 5 were used for this
study. Confluent monolayers were stimulated with TNF-alpha, IL-
1, lipopolysaccharide (LPS) or peptidoglycan (PGN). Production
of Chi3L1 and 2 was analysed in culture media after 24 or
48 h of exposure, using western blotting and specific antisera
recognizing the C-terminal peptides of rat or human Chi3L1 or
human Chi3L2. Cellular RNA was isolated from the cell-layers
and analysed by RT-PCR for mRNA levels of Chi3L1 and 2 as
well as for TLR type expression.
Results: Rat chondrocytes exposed to LPS produced large
quantities of Chi3L1, suggesting that its induction is a major com-
ponent of the TLR-4 response repertoire. Stimulation of intact rat
femoral heads resulted in a similar, strong induction of Chi3L1.
Analysis of RNA preparations from rat chondrocytes by RT-PCR
suggested that TLR-4 was the predominant receptor form.
In contrast to Chi3L1, Chi3L2 was not detectable in unstimulated
human chondrocytes. However, strong induction of Chi3L2 was
observed in cultures exposed to TNF-alpha or Il-1, suggesting a
similar regulatory process as described for rat Chi3L1. The most
potent induction was observed on exposure of the chondrocytes
to PGN, while LPS had only a mild stimulatory effect, suggesting
that in human articular chondrocytes, TLR-2 is the major form of
the receptor. Analysis of mRNA levels also indicated that TLR2
may be the major receptor expressed in these cells. Production of
Chi3L1 was also increased significantly following the addition of
inflammatory mediators. As for Chi3L2, activation of TLR-2, using
PGN, was more effective than activation of TLR-4, using LPS.
Conclusions: The expression of both the Chi3L1 and Chi3L2
genes has been associated with inflammatory and degenerative
arthritis. Our data show that production of the chitinase-like pro-
teins forms part of the response to activation of TLRs both in
rat and human articular chondrocytes, indicating that, although
the receptor repertoire may be different, the outcome is very
similar. Expression of Chi3L2 in human articular chondrocytes
is more stringently controlled than that of Chi3L1 and requires
activation of the inflammatory signalling cascade. However, the
concomitant increase of Chi3L1 production indicates that there
is a degree of coordinate regulation of the two proteins in an
inflammatory milieu. Thus the expression of Chi3L2 in degen-
erate human articular cartilage indicates the activation of the
inflammatory signalling cascade, which may be responsible for
the tissue damage associated with this condition.
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Purpose: In this study we investigated the frequency and locality
of progenitor cells throughout AHAC via antibodies directed to-
wards Stro-1 and Notch-1. Moreover, to document chondrogenic
activities, we stained for Sox9, a specific transcription regulator
of collagen type II.
Methods: Paraffin embedded AHAC (collected under local ethi-
cal guidelines) from healthy (n=9) and OA affected (n=9) donors
were sectioned and immuno stained for detection of Notch-1
(Mouse IgG, Abcam), Stro-1 (Mouse IgM, R&D Systems) and
Sox9 (Rabbit IgG, Chemicon). Species matched IgG or IgM
were used as negative controls. Assessment of positive signal
localizations throughout each cartilage zone included systematic
counting of positive and negative cells in a 50Ã‘Âμm x 50Ã‘Âμm
grid (40x field), starting from the cartilage surface down to the
base of the collected tissue specimen. This was repeated five
times for each section. The identification of each zone was based
on previously reported characteristics that comprise cell shape,
morphology, orientation and pericellular matrix (PM) deposition
(3). The depth of each zone was recorded for each section for
comparative analysis on the frequency of positive signal in each
zone. Comparisons between each zone and between normal
and OA tissue were made via T-tests.
